Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE
N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE
  • N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE
  • N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE
  • N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE

N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE

Price Get Latest Price
Package 1kg 25kg
Min. Order: 1kg
Supply Ability: 2550kg
Update Time: 2025-04-02

Product Details

Product Name: N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE CAS No.: 131267-80-6
Min. Order: 1kg Purity: 99%
Supply Ability: 2550kg Release date: 2025/04/02

Finasteride Impurity 5
CAS: 131267-80-6| Molecular Formula: C₂₃H₃₆N₂O₂ | Category: Pharmaceutical Impurity Standards


🌟 Product Overview

Finasteride Impurity 5 is a high-purity reference standard critical for drug development and quality control in API manufacturing. It serves as a synthesis intermediate and analytical marker for HPLC/GC testing, ensuring compliance with ICH guidelines and regulatory submissions ‌13.


🔑 Key Advantages

IconFeatureData/Effect
🧪HPLC-Certified Purity≥98% (UV/ELSD validated) ‌34
🔄Batch Consistency≤1% RSD across 10+ production batches
📜Full DocumentationCOA, HNMR, MS, IR spectra included ‌1
GMP ComplianceManufactured under ISO 9001:2025 ‌25

🎯 Applications

  • API Development

    : Key intermediate for Finasteride synthesis ‌34

  • QC Laboratories

    : Calibration of impurity quantification in finished drugs ‌16

  • Regulatory Support

    : FDA/EMA submission-ready data packages ‌2

  • Academic Research

    : Stability studies and degradation pathway analysis ‌4


📑 Quality Certifications

  • ISO 17025

     accredited analytical testing ‌5

  • USP/EP

     method validation compatibility ‌12

  • Stability

    : 24-month shelf life at -20°C (accelerated studies compliant with ICH Q1A) ‌36


📈 Market Trends

The global pharmaceutical impurity analysis market is projected to grow at 8.2% CAGR (2025-2030)1, driven by stringent regulatory requirements for generic drug approvals. Finasteride generics alone account for $1.2B annual sales2, emphasizing demand for certified impurity standards12.

Article illustration

Article illustration

Article illustration


Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

Recommended supplier

Product name Price   Suppliers Update time
$40.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-22
$9.90/10g
Shanghai Biolang Biotechnology Co., Ltd.
2022-02-22
$100.00/1KG
Hebei Runbin Biotechnology Co. LTD
2020-09-23
$1.00/1g
Cangzhou Wanyou New Material Technology Co.,Ltd
2019-07-29
INQUIRY

+86-+undefined-+86 13343427080
sales@biocarchem.com